Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells

Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells
复制标题

槐杞黄通过下调PRKCH并抑制RAF/MEK/ERK通路诱导Ph白血病细胞凋亡

DOI:
10.1007/s11596-020-2181-5
复制
发表时间:
2020-04
影响因子:
2.4
通讯作者:
Jin Run-ming
Jin Run-ming
中科院分区:
医学3区
文献类型:
--
作者:
Xu Wen-fu;Wang Zhu-jun;Li Kun;Shen Ya-qing;Lu Ke;Lv Xue-yan;Wen Yu-xi;Jin Run-ming

文献摘要

参考文献

相似文献

甲磺酸伊马替尼(IM)是费城(Ph)染色体阳性白血病的一线治疗药物,通过结合ABL激酶结构域抑制底物的磷酸化。由于耐药、副作用和IM的高成本,
Imatinib mesylate (IM) is the first-line treatment for Philadelphia (Ph) chromosomal positive leukemia by inhibiting phosphorylation of substrates via binding to the ABL kinase domain. Because of the drug resistance, side effects and the high cost of IM,
DOI: 10.1126/scisignal.3139re6
发表时间: 2010-09-14
期刊: Science signaling
影响因子: 7.3
作者:
Colicelli J
通讯作者: Colicelli J
DOI: 10.1158/0008-5472.can-06-0555
发表时间: 2006-06-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Cunningham, Steven C.;Gallmeier, Eike;Kern, Scott E.
通讯作者: Kern, Scott E.
DOI: --
发表时间: 2007
期刊: Nature medicine
影响因子: 82.9
作者:
T. Vilimas;J. Mascarenhas;Teresa Palomero;M. Mandal;S. Buonamici;Fanyong Meng;B. Thompson;Christina Sp
通讯作者: T. Vilimas;J. Mascarenhas;Teresa Palomero;M. Mandal;S. Buonamici;Fanyong Meng;B. Thompson;Christina Sp
DOI: 10.1182/blood-2015-04-639138
发表时间: 2015-11-05
期刊: BLOOD
影响因子: 20.3
作者:
Jones, Courtney L.;Gearheart, Christy M.;Carroll, William L.
通讯作者: Carroll, William L.
DOI: 10.1016/j.yonc.2012.07.028
发表时间: 2012
期刊: Yearbook of Oncology
影响因子: --
作者:
A. Hamilton;G. Helgason;M. Schemionek;Bin Zhang;S. Myssina;E. Allan;F. Nicolini;C. Müller-Tidow;R. Bhatia;V. Brunton;S. Koschmieder;T. Holyoake
通讯作者: A. Hamilton;G. Helgason;M. Schemionek;Bin Zhang;S. Myssina;E. Allan;F. Nicolini;C. Müller-Tidow;R. Bhatia;V. Brunton;S. Koschmieder;T. Holyoake